In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

EHJ – Cardiovascular Pharmacotherapy

Specific Focus on Clinical Cardiovascular Pharmacology


The European Heart Journal – Cardiovascular Pharmacotherapy (EHJ-CVP) is the official journal of the European Society of Cardiology and the ESC Working Group on Cardiovascular Pharmacotherapy. The journal reports on the interpretation and integration of new scientific developments  to improve the pharmacological treatment of patients with cardiovascular disease.

It publishes original articles on clinical research, with new and established drugs and methods, as well as meta-analysis and topical reviews.


Fast Facts

  • Editor-in-chief: Stefan Agewall FESC, NO
  • Current volume: 7 (year 2021)
  • Issues per subscription: 4
  • Impact Factor 2019: 6.696


Editor in chief History

Name Start Date End Date
 Professor Stefan Agewall 01/01/2015  
Updates on latest articles

Updates on latest articles


Receive the table of contents in your mailbox.

Track topics and authors important to you and receive articles in your mailbox.

For Authors

Before being published, all manuscripts go through double-blind, peer review by experienced international experts.

Most recent articles from EHJ-CVP

24 Dec 2020
Atrial fibrillation in registries
Author(s):Agewall S.
09 Jul 2020
Inhibitors of the renin–angiotensin–aldosterone system and COVID-19 in critically ill elderly patients
Author(s):Jung C, Bruno R, Wernly B, et al.
14 Jul 2020
Systemic fibrinolysis for acute pulmonary embolism complicating acute respiratory distress syndrome in severe COVID-19: a case series
Author(s):Della Bona R, Valbusa A, La Malfa G, et al.
07 May 2020
Choices in antithrombotic management for patients with atrial fibrillation undergoing percutaneous coronary intervention: questions (and answers) in chronological sequence
Author(s):Rubboli A, Valgimigli M, Capodanno D, et al.